Isfort, I; Elges, S; Cyra, M; Berthold, R; Renner, M; Mechtersheimer, G; Aman, P; Larsson, O; Ratner, N; Hafner, S; et al.
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
Scientific Reports.
2019;
9.
Choi, K; Ratner, N.
iGEAK: an interactive gene expression analysis kit for seamless workflow using the R/shiny platform.
BMC Genomics.
2019;
20.
Osum, S; Stemmer-Rachamimov, A; Widemann, B; Dombi, E; Vitte, J; Dahiya, S; Rizvi, T; Ratner, N; Messiaen, L; Gutmann, D; et al.
TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGINEERED MINIPIG MODEL OF NEUROFIBROMATOSIS TYPE 1.
Neuro-Oncology.
2019;
21:vi267-vi267.
Oatman, N; Dasgupta, N; Choi, K; Gawali, M; Gupta, N; Parameswaran, S; Lawler, S; Brennan, C; Wu, J; Sallans, L; et al.
CBMT-05. GENETIC AND EPIGENETIC MECHANISMS REGULATING SCD INHIBITOR SENSITIVITY IN GLIOBLASTOMA.
Neuro-Oncology.
2019;
21:vi33-vi33.
Ramkissoon, A; Chaney, KE; Milewski, D; Williams, KB; Williams, RL; Choi, K; Miller, A; Kalin, TV; Pressey, JG; Szabo, S; et al.
Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Clinical Cancer Research.
2019;
25:4117-4127.
Rauen, KA; Alsaegh, A; Ben-Shachar, S; Berman, Y; Blakeley, J; Cordeiro, I; Elgersma, Y; Evans, DG; Fisher, MJ; Frayling, IM; et al.
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
American Journal of Medical Genetics, Part A.
2019;
179:1091-1097.
Rice, FL; Houk, G; Wymer, JP; Gosline, SJ C; Guinney, J; Wu, J; Ratner, N; Jankowski, MP; La Rosa, S; Dockum, M; et al.
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
PLoS ONE.
2019;
14.
Hall, A; Choi, K; Liu, W; Rose, J; Zhao, C; Yu, Y; Na, Y; Cai, Y; Coover, RA; Lin, Y; et al.
RUNX represses Pmp22 to drive neurofibromagenesis.
Science advances.
2019;
5.
Hennigan, RF; Fletcher, JS; Guard, S; Ratner, N.
Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.
Science Signaling.
2019;
12.
Fletcher, JS; Springer, MG; Choi, K; Jousma, E; Rizvi, TA; Dombi, E; Kim, M; Wu, J; Ratner, N.
STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Oncogene.
2019;
38:2876-2884.
Fletcher, JS; Wu, J; Jessen, WJ; Pundavela, J; Miller, JA; Dombi, E; Kim, M; Rizvi, TA; Chetal, K; Salomonis, N; et al.
Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.
JCI insight.
2019;
4.
Agresta, L; Salloum, R; Hummel, TR; Ratner, N; Mangano, FT; Fuller, C; McMasters, RL; Pater, L; Jones, BV; Szabo, S; et al.
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Pediatric Blood and Cancer.
2019;
66.